Tarsons Products Stock Screener | Share Price & Fundamental Analysis
TARSONS
Medical Equipment
Share Price NSE
₹166.46
▼
-10.17 (-5.76%)
Share Price BSE
₹166.75
▼
-11.45 (-6.43%)
Track Tarsons Products share price live with TickJournal's free stock screener.
Analyze Tarsons Products share price history trends and compare 52-week high low
levels.
Record your trades in TickJournal's free trading journal and track your portfolio performance.
Tarsons Products Market Cap
₹939.78 Cr.
TARSONS P/E Ratio (TTM)
48.21
Tarsons Products P/B Ratio
1.56
EPS (TTM)
₹5.60
Dividend Yield
-
Debt to Equity
0.49
TARSONS 52 Week High
₹442.55
Tarsons Products 52 Week Low
₹166.46
Operating Margin
28.00%
Profit Margin
4.31%
TARSONS Revenue (TTM)
₹116.00
EBITDA
₹39.00
Net Income
₹5.00
Total Assets
₹1,080.00
Total Equity
₹630.00
Tarsons Products Share Price History - Stock Screener Chart
Screen TARSONS historical share price movements with interactive charts. Analyze price trends and patterns.
Tarsons Products Company Profile - Fundamental Screener
Screen Tarsons Products company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for TARSONS shares.
Sector
Healthcare
Industry
Medical Equipment
Sub-Sector
Medical Equipment
Segment
E
ISIN
INE144Z01023
Tarsons Products Balance Sheet Screener
Screen TARSONS balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2022 | 2021 |
|---|---|---|---|---|
| Assets | ||||
| Total Assets | 1,080 | 972 | 544 | 296 |
| Current Assets | 243 | 235 | 245 | 113 |
| Fixed Assets | 536 | 336 | 189 | 120 |
| Liabilities | ||||
| Total Liabilities | 0 | 0 | 0 | 0 |
| Current Liabilities | 274 | 146 | 20 | 10 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||
| Total Equity | 630 | 613 | 490 | 244 |
| Share Capital | 11 | 11 | 11 | 0 |
| Reserves & Surplus | 620 | 602 | 479 | 244 |
Tarsons Products Income Statement Screener - Profit & Revenue Analysis
Screen Tarsons Products income statement and profit fundamentals.
Analyze TARSONS quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Tarsons Products share price evaluation.
| Item | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Dec | 2022-Mar | 2021-Dec | 2021-Sept | 2021-Jun | 2021-Mar | 2020-Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 116 | 108 | 95 | 117 | 97 | 108 | 88 | 109 | 65 | 88 | 73 | 77 | 71 | 68 | 62 |
| Expenses | 78 | 75 | 67 | 76 | 66 | 74 | 66 | 76 | 39 | 41 | 38 | 38 | 32 | 33 | 30 |
| EBITDA | 39 | 33 | 28 | 41 | 31 | 34 | 22 | 34 | 26 | 47 | 36 | 40 | 39 | 36 | 32 |
| Operating Profit % | 28.00% | 27.00% | 27.00% | 33.00% | 31.00% | 26.00% | 22.00% | 29.00% | 37.00% | 52.00% | 47.00% | 50.00% | 53.00% | 52.00% | 51.00% |
| Depreciation | 25 | 23 | 20 | 20 | 17 | 14 | 11 | 12 | 10 | 7 | 5 | 5 | 5 | 3 | 4 |
| Interest | 6 | 5 | 5 | 5 | 5 | 5 | 4 | 4 | 3 | 0 | 1 | 2 | 1 | 1 | 1 |
| Profit Before Tax | 8 | 6 | 3 | 16 | 8 | 15 | 6 | 17 | 14 | 39 | 29 | 34 | 33 | 32 | 28 |
| Tax | 3 | 2 | 1 | 5 | 3 | 5 | 2 | 7 | 4 | 10 | 7 | 9 | 9 | 8 | 7 |
| Net Profit | 5 | 3 | 2 | 10 | 5 | 10 | 4 | 10 | 10 | 30 | 22 | 25 | 25 | 24 | 21 |
| EPS | 0.95 | 0.62 | 0.34 | 1.92 | 0.99 | 1.93 | 0.75 | 1.94 | 1.87 | 5.69 | 4.14 | 4.89 | 4.88 | 4.59 | 4.13 |
Tarsons Products Cash Flow Screener - Liquidity Fundamentals
Screen TARSONS cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2022-March | 2021-March |
|---|---|---|---|---|
| Operating Activities | 114 | 103 | 84 | 68 |
| Investing Activities | -145 | -285 | -138 | -64 |
| Financing Activities | 39 | 136 | 130 | -27 |
| Net Cash Flow | 8 | -47 | 75 | -23 |
Tarsons Products Shareholding Pattern Screener
See Tarsons Products shareholding pattern with promoter, FII, and DII holdings.
Check Tarsons Products promoter holding and ownership changes for TARSONS on TickJournal.
| Item | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 47.30% | 47.31% | 47.31% | 47.31% | 47.31% | 47.31% | 47.31% | 47.31% |
| FII Holding | 2.47% | 5.82% | 9.14% | 9.52% | 7.51% | 8.04% | 7.95% | 8.16% |
| DII Holding | 0.00% | 0.08% | 0.04% | 0.29% | 0.50% | 0.21% | 0.12% | 0.18% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 20.33% | 17.14% | 15.42% | 15.30% | 15.37% | 13.06% | 13.53% | 13.44% |
| Other Holding | 29.89% | 29.65% | 28.09% | 27.58% | 29.31% | 31.39% | 31.10% | 30.92% |
| Shareholder Count | 87,336 | 88,966 | 90,891 | 93,417 | 96,927 | 99,586 | 105,330 | 102,866 |
Tarsons Products Share Dividend Screener - Share Yield Analysis
Check Tarsons Products dividend history with payout and yield data.
View Tarsons Products dividend details including ex-dates and amounts for TARSONS stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.00 | 0.00% |
| 2024-March | ₹2.00 | 0.66% |
| 2023-March | ₹0.00 | 0.00% |
| 2022-March | ₹0.00 | 0.00% |
| 2021-March | ₹0.00 | 0.00% |
| 2020-March | ₹0.00 | 0.00% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Tarsons Products Stock Index Membership
See which indices include Tarsons Products stock.
Check TARSONS index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE 1000
BSE INDEX BSE HC
BSE INDEX SMLCAP
Tarsons Products Market Events Screener - Corporate Actions
Get Tarsons Products corporate actions including splits, bonuses, and buybacks.
Check Tarsons Products stock events that may affect TARSONS share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Annual General Meeting | NA | -17.14% | ||
| Annual General Meeting | NA | -2.81% | ||
| Dividend | ₹ 2.00 /share | 11.87% | ||
| 2026-02-06 | 2026-02-06 | Quarterly Result Announcement | NA | 5.73% |
| 2025-11-12 | 2025-11-12 | Quarterly Result Announcement | NA | -7.25% |
| 2025-08-12 | 2025-08-12 | Quarterly Result Announcement | NA | 0.51% |
| 2025-05-28 | 2025-05-28 | Quarterly Result Announcement | NA | 11.62% |
| 2025-02-14 | 2025-02-14 | Quarterly Result Announcement | NA | -9.49% |
| 2024-11-07 | 2024-11-07 | Quarterly Result Announcement | NA | 3.04% |
Tarsons Products Competitors Screener - Peer Comparison
Screen TARSONS competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Poly Medicure | 12,468 | 37.99 | 1,759 | 22.62% | 339 | 41.87 |
| Tarsons Products | 940 | 48.21 | 408 | 32.64% | 30 | 36.95 |
| Osel Devices | 926 | 46.75 | 187 | 40.62% | 20 | 55.13 |
| Laxmi Dental | 888 | 41.36 | 242 | 24.12% | 25 | 34.89 |
| Fabtech Technologies | 683 | 19.57 | 336 | 45.66% | 47 | 53.75 |
| Vasa Denticity | 610 | 48.53 | 251 | 45.01% | 17 | 26.16 |
| Prevest Denpro | 432 | 22.12 | 67 | 13.15% | 18 | 24.51 |
| Aprameya Engineering | 412 | 26.24 | 136 | 107.77% | 16 | 45.77 |
| Hemant Surgical Industries | 313 | 41.87 | 112 | % | 8 | 33.04 |
| Nureca | 216 | 20.93 | 122 | 19.24% | 1 | 27.81 |
Tarsons Products Company Announcements - News Screener
Screen TARSONS latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-03-28 | Closure of Trading Window | - |
| 2026-03-07 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-03-06 | Shareholder Meeting / Postal Ballot-Notice of Postal Ballot | - |
| 2026-02-11 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-02-10 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-02-09 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-02-06 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-02-06 | Announcement Of Equity Infusion In Our Wholly Owned Subsidiary Based In Singapore | - |
| 2026-02-06 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-02-06 | Announcement under Regulation 30 (LODR)-Resignation of Director | - |
| 2026-02-06 | Announcement under Regulation 30 (LODR)-Change in Directorate | - |
| 2026-02-06 | Announcement under Regulation 30 (LODR)-Change in Management | - |
| 2026-02-06 | Results For The Quarter And Nine Months Ended December 31 2025. | - |
| 2026-02-06 | Board Meeting Outcome for Outcome Of The Board Meeting Held On Friday February 06 2026 | - |
| 2026-01-30 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-01-30 | Board Meeting Intimation for The Quarter And Nine Months Ended December 31 2025 | - |
| 2026-01-08 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2025-12-23 | Closure of Trading Window | - |
| 2025-11-28 | Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011 | - |
| 2025-11-27 | Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - Further Investment In Tarsons Life Science Pte. Ltd. A Wholly-Owned Subsidiary Of The Company. | - |